In today’s briefing:
- NewMarket Corporation’s Unstoppable Petroleum Additives Profit Surge Exposes Shocking Cost-Cutting Secrets! – Major Drivers
- SSI’s 2024 Review: Portfolio Underperformance, Event-Driven Strategies, and Lessons from Losses
- [ETP 2025/01] WTI Rises on Improved Chinese Outlook, Henry Hub Reverses Uptrend
- Triumph Group’s Solid Cost-Cutting Efforts Skyrocket EBITDA Margins! – Major Drivers
- Valvoline Inc.: Expansion of Market Share & Franchise Growth As A Key Growth Catalyst! – Major Drivers
- Earth Venture Capital backs Mojave Energy Systems in US$9.5M Series A funding | e27
- Tri Pointe Homes: A Strong Liquidity Position Can Fuel Expansion! – Major Drivers
- Masimo Corporation: Here Are the 6 Most Critical Factors Shaping Its Performance in 2025 & Beyond! – Major Drivers
- Seres Therapeutics: Will Its Strategic Partnerships & Collaborations Prove to Be a Game-Changing Move?
- Sonoco Products: The Strategic Acquisition of Eviosys & Other Major Drivers
NewMarket Corporation’s Unstoppable Petroleum Additives Profit Surge Exposes Shocking Cost-Cutting Secrets! – Major Drivers
- NewMarket Corporation reported its financial results for the third quarter of 2024, presenting a mixed performance with noteworthy insights into its operations and strategic initiatives.
- In terms of financial performance, the company achieved a net income of $132 million, translating to $13.79 per share, compared to $111 million or $11.60 per share in the same period last year.
- This indicates an improvement in profitability on a year-over-year basis.
SSI’s 2024 Review: Portfolio Underperformance, Event-Driven Strategies, and Lessons from Losses
- SSI’s Tracking Portfolio ended 2024 with a -1% return, hindered by cash holdings and significant losses in MSTR, BHIL, and BOOM.
- SSI shared 85 investment ideas in 2024, including 14 Portfolio Ideas, 69 Quick Pitches, and 2 “Why I’m Not Involved” overviews.
- Portfolio Ideas suffered losses over 50% due to ignored red flags, while Quick Pitches had a 60% win rate.
[ETP 2025/01] WTI Rises on Improved Chinese Outlook, Henry Hub Reverses Uptrend
- For the week ending 27/Dec, U.S. crude inventories fell by 1.2m barrels, missing expectations of a 2.4m barrel decrease. Gasoline and distillate stockpiles rose more than expected.
- U.S. natural gas inventories fell by 116 Bcf for the week ending 27/Dec, missing analyst expectations of a 127 Bcf drawdown. Inventories are 4.7% above the 5-year seasonal average.
- JP Morgan lowered its 12-month PT for Halliburton and Schlumberger but maintained its “Overweight” ratings. Saudi Aramco revised fuel and natural gas prices for cement production starting from 01/Jan.
Triumph Group’s Solid Cost-Cutting Efforts Skyrocket EBITDA Margins! – Major Drivers
- Triumph Group presented a mix of performance outcomes in its second quarter fiscal 2025 results.
- The company demonstrated a commendable increase in its aftermarket growth, which surged 13% year-over-year and contributed over 60% to its profit.
- This was achieved through robust spares and repairs activities within both commercial and military sectors, setting a positive trend amid some broader market challenges.
Valvoline Inc.: Expansion of Market Share & Franchise Growth As A Key Growth Catalyst! – Major Drivers
- Valvoline Inc. announced its fourth-quarter and full fiscal year 2024 earnings, underlining its solid market position in the retail services sector, yet facing specific growth challenges.
- For fiscal 2024, Valvoline reported a significant 12% increase in system-wide store sales reaching $3.1 billion, along with adjusted EBITDA growth of 17% to $443 million.
- However, there were concerns as net revenue and same-store sales growth landed just below expectations.
Earth Venture Capital backs Mojave Energy Systems in US$9.5M Series A funding | e27
- Earth Venture Capital, a global climate tech firm backing deep-tech startups to decarbonise Emerging Asia, announced its participation in Mojave Energy Systems’ US$9.5 million Series A funding round.
- The investment, alongside the participation of Fifth Wall, At One Ventures, Myriad Venture Partners, Starshot Capital, and Alumni Ventures Group, raises Mojave’s total funding to US$25.6 million.
- In the next phase of innovation, Mojave plans to unveil ArctiDry HP, the first air conditioning system to integrate liquid desiccant technology with a reversible heat pump.
Tri Pointe Homes: A Strong Liquidity Position Can Fuel Expansion! – Major Drivers
- Tri Pointe Homes’ (TPH) latest financial results for the third quarter of 2024 present a combination of robust performance metrics and strategic market positioning, alongside noted challenges in certain geographies and market segments.
- As a residential home builder operating across diverse U.S. markets, Tri Pointe achieved notable gains in home deliveries, revenue growth, and profitability, yet remains vigilant of macroeconomic and regional headwinds impacting future outlook.
- Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.
Masimo Corporation: Here Are the 6 Most Critical Factors Shaping Its Performance in 2025 & Beyond! – Major Drivers
- Masimo Corporation, a global technology company focused on experienced healthcare solutions, recently reported its financial results for the third quarter of 2024.
- The company’s healthcare segment demonstrated robust performance, with revenues reaching $343 million, showcasing a 12% year-over-year growth.
- This growth was attributed to increased consumable and service revenues, although partially offset by a decline in capital equipment sales.
Seres Therapeutics: Will Its Strategic Partnerships & Collaborations Prove to Be a Game-Changing Move?
- Seres Therapeutics has outlined significant developments and strategic decisions during its third-quarter 2024 update.
- The company achieved notable milestones, primarily around its lead clinical candidate, SER-155, and its corporate financial structure, significantly influenced by the sale of its VOWST program to Nestlé Health Science.
- Seres reported positive data from its Phase Ib clinical trial for SER-155, indicating a potential for reducing bacterial bloodstream infections (BSIs) in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Sonoco Products: The Strategic Acquisition of Eviosys & Other Major Drivers
- Sonoco Products reported a solid financial performance for the third quarter of 2024, showcasing a resilient operational model amidst challenging external conditions, such as the disruptions caused by Hurricanes Helene and Milton.
- The company achieved adjusted EBITDA of $281 million, representing a 16.8% margin, and adjusted earnings per share (EPS) of $1.49.
- Operating cash flow reached $162 million during this period.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
